Eidos Therapeutics, Inc.

Report date
12/31/2020
Quarter
2020 Q4
Filed
2/12/2021
Shares
1,120
Value ($000)
148
Weight
0.0%
2020 Q3 - 2020 Q4 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).